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I 
INTRODUCTION 
Despite assurances from healthcare providers, questions about vaccine 
safety remain in the media spotlight and public debate, particularly the concern 
that vaccines cause autism. Since 2002, the federal court that hears vaccine-
injury disputes—commonly called the Vaccine Court—has been at the center of 
a debate about whether vaccines cause autism.1 The year 2010 marked the 
conclusion of six cases selected to test the validity of theories about how 
vaccines cause autism.2 In August 2010, a final decision was rendered in the last 
unresolved test case, Cedillo v. Department of Health & Human Services.3 In 
Cedillo, the Federal Circuit affirmed the Vaccine Court’s finding that the 
petitioner neither presented a viable theory about how vaccines cause autism, 
nor proved that the petitioner’s vaccination caused her autism. 
This decision affects approximately five thousand similar autism claims 
pending in the Vaccine Court.4 Many families involved in these claims assert 
that the test cases satisfied the court’s unique standard of proof, whereas the 
federal government argues that the cases failed to meet even a low standard.5 In 
light of the complex, competing scientific claims considered by the court, the 
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 1.  In re Claims for Vaccine Injuries Resulting in Autism Spectrum Disorder or a Similar 
Neurodevelopmental Disorder, 2002 WL 31696785, at *1 (Fed. Cl. July 3, 2002) [hereinafter July 2002 
Autism Update]. 
 2.  In re Claims for Vaccine Injuries Resulting in Autism Spectrum Disorder or a Similar 
Neurodevelopmental Disorder (Fed. Cl. filed Sept. 29, 2010) [hereinafter Sept. 2010 Autism Update], 
available at http://www.autism-watch.org/omnibus/update.shtml. 
 3.  No. 98-916V, 2009 WL 331968 (Fed. Cl. Feb. 12, 2009), reconsideration denied, No. 98-916V, 
2009 WL 996299 (Fed. Cl. Mar. 16, 2009), and aff’d, No. 98-916V, 2009 WL 2998429 (Fed. Cl. Aug. 6, 
2009), aff’d, 617 F.3d 1328 (Fed. Cir. 2010). 
 4.  Sept. 2010 Autism Update, supra note 2. 
 5.  Wendy N. Davis, The Immune Response: The Supreme Court May Tell Families with Autistic 
Children Whether They Can Sue Vaccine Makers, 96 A.B.A. J. 48, 52 (2010). 
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autism test case decisions raise significant “science and law” issues.6 Throughout 
the autism test cases, there has been an overarching concern that a decision to 
deny entitlement will result in a flood of autism claims in state courts. But 
considering current scientific and medical knowledge, the concern over autism 
cases moving into the civil sphere is likely overstated. Instead, attention should 
be paid to how these autism claims reflect a broader concern: a loss of public 
trust in vaccines. 
The conclusion of the autism test cases is an opportunity to review the 
success of the vaccine-injury program and its relationship to U.S. vaccination 
practices. Part II of this note traces the history of vaccine-injury suits in the 
United States, the creation of the Vaccine Court, and how vaccine-injury claims 
are proven in the court. Part III introduces the vaccine–autism controversy and 
the Vaccine Court’s decision to institute an omnibus proceeding to manage the 
autism claims. Part IV provides an overview of the omnibus autism proceedings, 
focusing on the Cedillo case. Part V sets forth an argument that the autism test 
cases demonstrate how the current standard of proof in vaccine cases trends too 
much toward awarding compensation and away from science. Vaccine Court 
decisions are unlikely to restore public trust in vaccines, but the decisions can 
contribute to public misperceptions. Compensating too many undeserving 
petitioners undermines the integrity of vaccine safety. Accordingly, this 
threatens to create a public health problem: If the standard of proof in the 
Vaccine Court is too low, the court implicitly validates public fears about 
vaccines and impacts public willingness to get vaccinated. To maintain public 
trust in vaccines, the standard of proof in the Vaccine Court must be clearer and 
more scientifically rigorous. 
II 
THE HISTORY OF VACCINE LITIGATION AND POLICY 
A. Vaccine-Injury Lawsuits in the United States 
Every state legally requires that children receive certain immunizations 
before attending school or daycare.7 Many states provide medical, religious, and 
even philosophical exemptions to vaccination requirements.8 Nevertheless, most 
children in the United States today receive routine immunizations against 
fourteen diseases.9 In rare cases, vaccines cause serious and even fatal side-
 
 6.  Joëlle Anne Moreno, It’s Just a Shot Away: MMR Vaccines and Autism and the End of the 
Daubertista Revolution, 35 WM. MITCHELL L. REV. 1511, 1517–18 (2009). 
 7.  Gordon Shemin, Mercury Rising: The Omnibus Autism Proceeding and What Families Should 
Know Before Rushing Out of Vaccine Court, 58 AM. U. L. REV. 459, 468 (2008) (“Today all fifty states 
as well as the District of Columbia mandate childhood immunizations.”). 
 8.  See, e.g., Toward a Twenty-First-Century, 121 HARV. L. REV. 1820, 1825 (2008) (stating that 
most states allow religious exemptions and some provide philosophic exemptions to vaccination 
requirements). 
 9.  Frontline: The Vaccine Wars (PBS television broadcast Apr. 27, 2010). 
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effects.10 These side-effects can occur even if vaccines are produced and 
administered properly.11 
In the mid- to late 1980s, there was a significant increase in the number of 
vaccine-injury suits against vaccine manufacturers,12 possibly attributable to 
heightened media coverage at the time about the risks of vaccinations. Media 
coverage primarily focused on the diphtheria–tetanus–pertussis (DTP) 
vaccine.13 Plaintiffs in these suits often sought millions in damages.14 
Manufacturers worried that juries would award substantial damages to 
sympathetic plaintiffs regardless of whether the manufacturers were at fault.15 
Experiencing difficulty obtaining liability insurance, some manufacturers 
withdrew from the market. Ultimately, only one commercial DTP manufacturer 
remained in the U.S. market.16 In December 1984, the Centers for Disease 
Control and Prevention (CDC) predicted the United States would experience 
vaccine shortages as early as January 1985.17 
B. The Vaccine Act 
In 1986, Congress responded to the threat of a vaccine-supply crisis by 
passing the National Childhood Vaccine Injury Act of 1986 (the Vaccine Act).18 
The Vaccine Act created a no-fault program for resolving vaccine-injury 
claims.19 Key features of this program are its relaxed procedures and unique 
standard of proof. 
1. The Vaccine Court 
The Vaccine Act created a comprehensive vaccine policy for the United 
States. This policy included a National Vaccine Injury Compensation Program 
(NVICP or the Vaccine Program), designed to be more accessible and less 
 
 10.  See, e.g., Okianer Christian Dark, Is the National Childhood Vaccine Injury Act of 1986 the 
Solution for the DTP Controversy?, 19 U. TOL. L. REV. 799, 800, 802 (1994) (stating that for some 
children, “the [DTP] vaccine is extremely dangerous” and that “even when manufactured and 
distributed properly, can cause serious injuries, including death,” but noting that vaccine side-effects 
are rare). 
 11.  Id. at 801 (discussing vaccine manufacturers’ concerns that unavoidable vaccine side-effects 
would expose them to liability without wrongdoing). 
 12.  See, e.g., id. at 820, 831–32 (discussing the history of suits against vaccine manufacturers). 
 13.  Alan R. Hinman, DTP Vaccine Litigation, 140 AM. J. DISEASES CHILD. 528, 529 (1986). 
 14.  James O. Mason, Vaccine Supply and Liability, 101 PUB. HEALTH REP. 229, 229 (1986). 
 15.  See James B. Currier, Too Sick, Too Soon?: The Causation Burden Under the National Vaccine 
Injury Compensation Program Following De Bazan v. Secretary of Health and Human Services, 19 
FED. CIR. B.J. 229, 233 (2009) (noting that later studies confirmed most juries sympathized with 
vaccine-injury plaintiffs).  
 16.  Mason, supra note 14, at 229. 
 17.  Ctr. for Disease Control and Prevention, Diphtheria-Tetanus-Pertussis Vaccine Shortage—
United States, 34 MORBIDITY MORTALITY WKLY. REP. WKLY. 695 (1984), 
http://www.cdc.gov/mmwr/preview/mmwrhtml/00000452.htm. 
 18.  Pub. L. 99-660, title III, Sec. 311(a), Nov. 14, 1986, 100 Stat. 3758. 
 19.  42 U.S.C.A. § 300aa-1 (West 2011). 
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adversarial than the traditional tort system.20 To adjudicate vaccine-injury 
claims, the NVICP created an Office of Special Masters (OSM) in the United 
States Court of Federal Claims (CFC),21 unofficially dubbed the Vaccine 
Court.22 
Petitioners must file vaccine-injury claims with the Vaccine Court before 
filing in state court.23 Special masters, without a jury, issue decisions on 
entitlement.24 The Secretary of Health and Human Services (HHS) serves as the 
respondent.25 Petitioners are not required to obtain legal counsel, but may 
request reasonable attorneys’ fees regardless of the outcomes of their claims.26 
Within thirty days after a petitioner files a claim with the Vaccine Court, the 
special master assigned to the case holds a status conference with the parties to 
assess the merits of the petitioner’s claim and facilitate settlement.27 If the case 
goes forward, the Vaccine Court has 240 days to issue a decision or the 
petitioner can exit the program and bring a claim in state court.28 After the 
Vaccine Court issues a decision, a dissatisfied petitioner generally retains the 
right to reject the judgment and file in state court.29 Additionally, either party 
may apply to the CFC for review of a special master’s decision and appeal a 
CFC decision to the U.S. Court of Appeals for the Federal Circuit.30 
2. Proving a Claim in the Vaccine Court 
To receive compensation, petitioners must prove they suffered one of two 
kinds of injuries: “on-table” or “off-table.” On-table injuries are those listed in 
the NVICP Vaccine Injury Table.31 This table includes adverse events known by 
the medical community to occur after a vaccination.32 Injuries not on the table 
or not occurring within the table’s timeframe constitute off-table claims. If a 
petitioner proves, by a preponderance of the evidence, that he suffered an on-
table injury following an immunization, the Vaccine Court presumes the 
 
 20.  Id. § 300aa-10; see also Dark, supra note 10, at 803 (stating the Vaccine Act was intended to 
provide “an alternative to the tort law system”). 
 21.  Vaccine Program Background, U.S. CT. FED. CLAIMS OFF. SPECIAL MASTERS, 
http://www.uscfc.uscourts.gov/sites/default/files/vaccine.background.2010.pdf (last visited Jan. 3, 2010). 
 22.  Mark Sherman, Parents Lose Supreme Court Appeal in Vaccine Case, U.S. NEWS & WORLD 
REP. (Feb. 22, 2011), available at http://www.usnews.com/news/articles/2011/02/22/parents-lose-high-
court-appeal-in-vaccine-case. 
 23.  42 U.S.C.A. § 300aa-11(a)(2)(A). 
 24.  Id. § 300aa-12(d). 
 25.  Id. § 300aa-12(b)(1). 
 26.  See, e.g., Alexandra M. Stewart, When Vaccine Injury Claims Go to Court, 360 NEW ENG. J. 
MED. 2498, 2498 (2009) (describing the NVICP process). 
 27.  VACCINE R. OF U.S. COURT OF FED. CLAIMS 5. 
 28.  42 U.S.C.A. § 300aa-21(b).  
 29.  Id. Some claims, however, can only be brought in the Vaccine Court. Id. § 300aa-22. 
 30.  Id. § 300aa-12(e), (f). 
 31.  The original Vaccine Injury Table can be found at 42 U.S.C.A. §§ 300aa-14(a). The amended 
table can be found at 42 C.F.R § 100.3 (2011). 
 32.  E.g., Stewart, supra note 26, at 2498. 
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vaccine was the cause.33 To succeed with an off-table injury, a petitioner must 
prove, by a preponderance of the evidence, that the vaccine was the cause-in-
fact of the injury.34 To prevent successful claims from effectively creating more 
on-table injuries, decisions by special masters or the CFC are not binding on 
special masters, except on remand in the same case.35 Originally, Congress 
assumed that the majority of petitioners would file on-table claims. Recently, 
however, the number of off-table claims has increased.36 
The Vaccine Act explicitly forbids the court from finding actual causation 
based solely on a petitioner’s statements unsupported by medical records or 
expert medical opinion.37 Although the Vaccine Act does not require expert 
testimony, experts have played an increasingly important role in successful off-
table vaccine-injury claims (not unlike non-vaccine litigation).38 This has 
spurred numerous Federal Circuit decisions addressing what evidence is 
necessary and sufficient to prove an off-table injury. These opinions have set a 
low evidentiary bar: For example, in Knudsen v. Secretary of Department of 
Health & Human Services, the Federal Circuit reversed and remanded a special 
master’s decision to deny entitlement, stating that the petitioner’s theory of 
causation needed only to be “‘logical’ and legally probable, not medically or 
scientifically certain.”39 The court explained, “to require [the] identification and 
proof of specific biological mechanisms would be inconsistent with the purpose 
and the nature of the vaccine compensation program. The Vaccine Act does not 
contemplate full blown tort litigation.”40 In a later case, the Federal Circuit 
supported this interpretation of the standard of proof, citing Congress’s 
acknowledgement that the Vaccine Program would compensate some 
petitioners whose injuries were not actually vaccine-related.41 In another case, 
 
 33.  42 U.S.C.A § 300aa-13(a)(1); see also Althen v. Sec’y of Health & Human Servs., 418 F.3d 
1274, 1278 (Fed. Cir. 2005) (“The Act provides for the establishment of causation . . . through a 
statutorily-prescribed presumption of causation upon a showing that the injury falls under the Vaccine 
Injury Table (‘Table Injury’).”). 
 34.  42 U.S.C.A §§ 300aa-11(c)(1)(C)(ii)–13(a)(1)(A). 
 35.  E.g., Hanlon v. Sec’y of Health & Human Servs., 40 Fed. Cl. 625, 630 (1998) (“Special Masters 
are neither bound by their own decisions nor by cases from the Court of Federal Claims, except . . . on 
remand.”). 
 36.  This is partly because HHS modified the Vaccine Injury Table in the 1990s and removed some 
of the more common injuries. See, e.g., Currier, supra note 15, at 247 (“HHS redefined the number of 
compensable injuries on the Injury Table. Although HHS added more vaccines to the Injury Table than 
it removed, the vaccines removed were involved in a large proportion of the claims before the vaccine 
courts.”); Katherine E. Strong, Proving Causation Under the Vaccine Injury Act: A New Approach for a 
New Day, 75 GEO. WASH. L. REV. 426, 443 (2007) (stating HHS modified the table based on reports 
from the Institute of Medicine about whether certain vaccines caused particular injuries). 
 37.  42 U.S.C.A. § 300aa-13(a)(1) (“The special master or court may not make such a finding based 
on the claims of a petitioner alone, unsubstantiated by medical records or by medical opinion.”). 
 38.  See, e.g., Currier, supra note 15, at 247 (stating that scholars have noted the increasing 
importance of expert testimony and medical studies in Vaccine Court cases). 
 39.  35 F.3d 543, 548–49 (Fed. Cir. 1994). 
 40.  Id. at 549. 
 41.  Shyface v. Sec’y of Health & Human Servs., 165 F.3d 1344, 1351 (Fed. Cir. 1999) (“The 
HAERTLEIN 3/20/2012 11:13 AM 
216 LAW AND CONTEMPORARY PROBLEMS [Vol. 75:211 
 
the Federal Circuit objected to the special master’s requiring peer-reviewed 
literature linking a petitioner’s vaccine and injury. The court stated that it saw 
“no ‘objective confirmation’ requirement in the Vaccine Act’s preponderant 
evidence standard.”42 
In Althen v. Secretary of Health & Human Services, the Federal Circuit 
announced a new, three-prong standard of proof for off-table claims.43 Under 
Althen, petitioners must present “(1) a medical theory causally connecting the 
vaccination and the injury; (2) a logical sequence of cause and effect showing 
that the vaccination was the reason for the injury; and (3) a showing of a 
proximate temporal relationship between vaccination and injury.”44 If a 
petitioner satisfies all three prongs, the government must prove, by a 
preponderance of the evidence, an alternate cause for the petitioner’s injury. 
The Federal Circuit stated that “close calls regarding causation are resolved in 
favor of injured claimants.”45 The CFC has characterized the petitioner’s burden 
as needing only to “to ‘tip the scale’ by the slightest of evidentiary margins.”46 
Before Althen, the Federal Circuit stated that a petitioner’s proof of 
causation must be supported by reliable scientific or medical explanations.47 The 
Federal Circuit affirmed a special master’s refusal to credit an expert opinion 
without support from medical literature or studies, remarking that “[a]n expert 
opinion is no better than the soundness of the reasons supporting it,”48 and 
acknowledged that Congress intended special masters to have broad discretion 
to assess vaccine-injury evidence.49 Even post-Althen, the Federal Circuit 
remarked that “[a]lthough a Vaccine Act claimant is not required to present 
proof of causation to the level of scientific certainty, the special master is 
entitled to require some indicia of reliability to support the assertion of [an] 
 
Committee further recognizes that the deeming of vaccine-relatedness adopted here may provide 
compensation to some children whose illness is not, in fact, vaccine-related.”) (quoting H.R. REP. NO. 
99-908, at 18 (1986), reprinted in 1986 U.S.C.C.A.N. 6344, 6359).  
 42.  Althen v. Sec’y of Health & Human Servs., 418 F.3d 1274, 1279 (Fed. Cir. 2005). 
 43.  Id. at 1278; see also Davis, supra note 5, at 52 (“[T]he Federal Circuit relaxed the causation 
standard in 2005 . . . . The special master denied Althen compensation because [the petitioner] hadn’t 
proved that the vaccine caused her condition, but the appellate court reversed—and announced a new 
standard.”). 
 44.  Althen, 418 F.3d at 1278. 
 45.  Id. at 1280. 
 46.  McClendon v. Sec’y of Dep’t Health & Human Servs., 24 Cl. Ct. 329, 333 (1991). 
 47.  See, e.g., Knudsen v. Sec’y of Dep’t of Health & Human Servs., 35 F.3d 543, 548 (Fed. Cir. 
1994) (“This ‘logical sequence of cause and effect’ must be supported by a sound and reliable medical 
or scientific explanation.”); Grant v. Sec’y of Dep’t of Health & Human Servs., 956 F.2d 1144, 1148 
(Fed. Cir. 1992) (“A reputable medical or scientific explanation must support this logical sequence of 
cause and effect.”). 
 48.  Perreira v. Sec’y of Dep’t of Health & Human Servs., 33 F.3d 1375, 1377 n.6 (Fed. Cir. 1994) 
(citing Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993)). 
 49.  Whitecotten v. Sec’y of Health & Human Servs., 81 F.3d 1099, 1108 (Fed. Cir. 1999) 
(“Congress desired the special masters to have very wide discretion with respect to the evidence they 
would consider and the weight to be assigned to [it].”). 
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expert witness.”50 The Federal Circuit has confirmed recently that special 
masters may use Daubert factors to evaluate the reliability of scientific evidence 
presented in vaccine cases.51 In Daubert v. Merrell Dow Pharmaceuticals, Inc., 
the Supreme Court announced the standard by which judges determine the 
admissibility of expert witness testimony in federal courts: the scientific validity 
of the underlying reasoning or methodology and its proper application to the 
facts of the case.52 The Court specifically stated that judges may consider 
whether the theory can or has been tested, whether it has been published or 
peer-reviewed, and its reception in the scientific community.53 Nevertheless, 
since Althen, the Federal Circuit has reversed and remanded a number of 
Vaccine Court decisions for impermissibly raising the standard of proof.54 The 
autism cases demonstrate the possible practical consequences of the current low 
standard of proof on vaccination practices, underscoring the need for a more 
scientific standard. 
III 
THE VACCINE–AUTISM CONTROVERSY 
A. Linking Vaccines to Autism 
Since 1999, the Vaccine Court has received more than five thousand claims 
alleging that a vaccine caused or contributed to a petitioner’s autism.55 To 
understand the impact of these autism cases, it is important to know the history 
of the vaccine–autism controversy. 
Autism spectrum disorders, which vary in degrees of severity, include 
complex conditions that affect individuals’ abilities to interact socially and 
communicate. Symptoms typically emerge before age three.56 There is no 
laboratory test for autism; diagnosis is based on certain behavioral criteria.57 
Since the 1980s, autism diagnoses have been on the rise in the United States, 
increasing public awareness about the disorder and fueling speculations about 
possible causes.58 
 
 50.  Moberly v. Sec’y of Health & Human Servs., 592 F.3d 1315, 1324 (Fed. Cir. 2010). 
 51.  See, e.g., Cedillo v. Sec’y of Health & Human Servs., 617 F.3d 1328, 1338 (Fed. Cir. 2010) (“We 
see no legal error in the standards applied by the Special Master either in judging causation or in 
utilizing Daubert.”); Terran v. Sec’y of Health & Human Servs., 195 F.3d 1302, 1316 (Fed. Cir. 1999). 
 52.  Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). 
 53.  Id. at 593–95. 
 54.  See, e.g., Andreu v. Sec’y of Health & Human Servs., 569 F.3d 1367 (Fed. Cir. 2009); 
Capizzano v. Sec’y of Health & Human Servs., 440 F.3d 1317 (Fed. Cir. 2006). 
 55.  Regina Moreland, National Vaccine Injury Compensation Program: The Potential Impact of 
Cedillo for Vaccine-Related Autism Cases, 29 J. LEGAL MED. 363, 364 (2008).  
 56.  Liza Gross, A Broken Trust: Lessons from the Vaccine–Autism Wars, 7 PLOS BIOLOGY, May 
2009, at 1, 5 (2009).  
 57.  Shemin, supra note 7, at 478 (“The etiology of autism remains a mystery and science has not 
yet been able to determine a cause.”).  
 58.  See, e.g., Gross, supra note 56, at 4 (discussing the rise in autism diagnoses and public theories 
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The vaccine–autism theory is often attributed to British physician Andrew 
Wakefield. In 1998, Wakefield published an article in The Lancet linking the 
measles–mumps–rubella (MMR) vaccine to autism. The Lancet later retracted 
Wakefield’s article, and in May 2010, Wakefield lost his medical license for 
reasons that included unethical conduct related to his autism research.59 
In the United States, the vaccine–autism controversy has centered on 
thimerosal.60 Thimerosal is an ethylmercury compound that has been used as a 
preservative in vaccines since the 1930s.61 In the late 1990s, the FDA indicated 
that thimerosal-containing vaccines might expose children to mercury levels 
exceeding federal safe-intake guidelines.62 Subsequently, the federal Public 
Health Service and American Academy of Pediatrics issued joint statements 
recommending thimerosal be removed from vaccines—both as a precautionary 
measure and as an effort to maintain public confidence in vaccine safety.63 
Today, as many as one in four Americans believe that vaccines can cause 
autism.64 The media has only inflamed the public’s fears. News reports have 
cited studies linking thimerosal to autism and have featured scientists who 
supported the theory.65 A number of high-profile politicians and celebrities have 
discussed the theory publically. In 2005, Rolling Stone magazine published an 
article by Robert Kennedy, Jr.—son of the late Senator Robert Kennedy—
called “Deadly Immunity,” in which Kennedy stated, “If, as the evidence 
suggests, our public-health authorities knowingly allowed the pharmaceutical 
industry to poison an entire generation of American children, their actions 
arguably constitute one of the biggest scandals in the annals of American 
medicine.”66 In 2008, celebrity Jenny McCarthy, whose son is autistic, appeared 
on Larry King’s show on CNN and argued that vaccines can cause autism.67 The 
vaccine–autism theory persists in public discourse at least in part because of 
media attention and affirmations from high-profile sources. 
 
about the causes). 
 59.  Davis, supra note 5, at 53 (“Earlier this year, The Lancet retracted Wakefield’s article, stating 
that ‘several elements’ of the paper were incorrect.”); Gross, supra note 56, at 1 (“Wakefield faces 
charges of serious professional misconduct before the General Medical Council (GMC) for allegedly 
violating ethical research practices on several counts.”); Davis, supra note 5, at 53 (“Wakefield was 
stripped of his medical license in May.”). 
 60.  Gross, supra note 56, at 1 (describing the history of the vaccine–autism controversy in the 
United Kingdom and United States). 
 61.  Shemin, supra note 7, at 461 n.8. 
 62.  Moreland, supra note 55, at 370. 
 63.  Id. at 371. 
 64.  Gross, supra note 56, at 2. 
 65.  See, e.g., id. at 6 (discussing published accounts of scientists who support the vaccine–autism 
theory).  
 66.  Robert Kennedy Jr., Deadly Immunity, ROLLING STONE, June 20, 2005, available at 
http://www.rollingstone.com/plus/archive#/2/329/56/S.  
 67.  Larry King Live (CNN television broadcast Feb. 28, 2008); see also Gross, supra note 56, at 5 
(describing news and media coverage of the vaccine–autism controversy). 
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B. The Omnibus Autism Proceedings 
“At its inception, it was unforeseen the [Vaccine] Program would receive 
over 5,000 cases in eight years arguing a link between a vaccine and autism.”68 A 
central question became how the Vaccine Program would manage the flood of 
cases. In 2002, the Vaccine Court created the Omnibus Autism Proceedings 
(OAP), which designated specific procedures for “aggressively, but fairly” 
resolving pending and anticipated autism claims.69 Special Master George 
Hastings, Jr. was selected to preside over the OAP.70 Shortly after he was 
chosen, Special Masters Denise Vowell and Patricia Campbell-Smith were also 
assigned to the OAP.71 
Because autism is an off-table claim, petitioners must prove causation-in-
fact.72 The OAP employed a two-step process for resolving the autism claims. 
First, the special masters would conduct an inquiry into the issue of general 
causation: whether vaccines can cause autism. Second, the special masters 
would apply their evidentiary findings from the general-causation inquiry to the 
individual autism cases.73 OSM selected attorneys representing petitioners in 
autism claims to constitute the Petitioner’s Steering Committee (PSC).74 PCS 
selected general-causation-theory test cases for the OAP. Petitioners with 
pending or potential autism claims could opt into the OAP. Special masters 
would defer proceedings for cases in the program until after deciding the test 
cases.75 
Ultimately, PSC presented two general-causation theories, selecting three 
test cases for each theory. The first theory alleged that the MMR vaccine and 
thimerosal-containing vaccines together can cause autism. The second theory 
alleged that thimerosal-containing vaccines alone can cause autism.76 PSC 
selected as the first theory test cases Cedillo v. Secretary of Health & Human 
Services,77 Hazlehurst v. Secretary of Department of Health & Human Services,78 
 
 68.  Moreland, supra note 55, at 364; see also July 2002 Autism Update, supra note 1, at *1 
(“Processing such a large number of cases [would] stretch thinly the resources of both the court and the 
bar.”). 
 69.  E.g., Shemin, supra note 7, at 461. 
 70.  July 2002 Autism Update, supra note 1, at *3. 
 71.  The Autism Proceedings, U.S. CT. FED. CLAIMS OFF. SPECIAL MASTERS, 
ftp://ftp.cafc.uscourts.gov/autism/vaccine/Background_on_the_autism_proceedings.pdf (last visited Jan. 
3, 2010).  
 72.  E.g., Shemin, supra note 7, at 476 (“Because autism is not listed as an injury on the Vaccine 
Injury Table, claims alleging autism must proceed via the off-table theory.”). 
 73.  July 2002 Autism Update, supra note 1, at *2 (creating the OAP framework and Docket of the 
OAP, a public compilation of filings, court orders, decisions, and updates from the court). 
 74.  The Autism Proceedings, supra note 71; Health Res. and Servs. Admin., National Vaccine 
Injury Compensation Program: About the Omnibus Autism Proceedings, U.S. DEP’T HEALTH & HUM. 
SERVS., http://www.hrsa.gov/vaccinecompensation/omnibusautism.html (last updated Aug. 19, 2010). 
 75.  July 2002 Autism Update, supra note 1, at *6. 
 76.  Sept. 2010 Autism Update, supra note 2. 
 77.  No. 98-916V, 2009 WL 331968 (Fed. Cl. Spec. Mstr. Feb. 12, 2009). 
 78.  No. 03-654V, 2009 WL 332258 (Fed. Cl. Spec. Mstr. Feb. 12, 2009). 
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and Snyder v. Secretary of Department of Health & Human Services.79 The 
second theory test cases were Mead v. Secretary of Health & Human Services,80 
King v. Secretary of Health & Human Services,81 and Dwyer v. Secretary of 
Department of Health & Human Services.82 The three special masters assigned 
to the OAP would hear the general-causation evidence jointly, but would 
separately decide each case assigned to them.83 In 2007, the special masters 
conducted three weeks of evidentiary hearings on the first theory. Michelle 
Cedillo’s case was the first to begin.84 
IV 
THE AUTISM TEST CASE DECISIONS 
A. Michelle Cedillo’s Case 
For the first two years of Michelle Cedillo’s life, she was apparently a 
healthy child.85 In December 1995, Michelle received an MMR vaccine and one 
week later developed a high fever.86 In January, she had a second fever, and 
Michelle’s pediatrician diagnosed her with “sinusitis v. flu.”87 At her next doctor 
visit, Michelle’s pediatrician noted that Michelle was “talking less” since the 
fever.88 In 1997, a different pediatrician noted Michelle’s development was 
delayed, suspecting the fevers had caused neurological damage but unable to 
determine if it was a “post-immunization phenomenon.”89 That same year, a 
developmental psychologist diagnosed Michelle with “severe Autism” and 
“profound Mental Retardation.”90 
The Cedillos filed a petition in the Vaccine Court, alleging that multiple 
thimerosal-containing vaccines had damaged Michelle’s immune system.91 They 
claimed this damage allowed the live measles virus in the MMR vaccine to 
replicate in Michelle’s body and cause inflammation in her bowels and brain.92 
Michelle’s case was grouped into the OAP. At the request of the PCS and the 
 
 79.  No. 01-162V, 2009 WL 332044 (Fed. Cl. Spec. Mstr. Feb. 12, 2009). 
 80.  No. 03-215V, 2010 WL 892248 (Fed. Cl. Spec. Mstr. Mar. 12, 2010). 
 81.  No. 03-584V, 2010 WL 892296 (Fed. Cl. Spec. Mstr. Mar. 12, 2010). 
 82.  No. 03-1202V, 2010 WL 892250 (Fed. Cl. Spec. Mstr. Mar. 12, 2010). 
 83.  Sept. 2010 Autism Update, supra note 2. 
 84.  In re Claims for Vaccine Injuries Resulting in Autism Spectrum Disorder or a Similar 
Neurodevelopmental Disorder, Order Concerning Case Processing (Fed. Cl. Spec. Mstr. June 5, 2007), 
http://www.uscfc.uscourts.gov/sites/default/files/autism/Untitled.pdf. 
 85.  Before two years of age, Michelle reached her developmental milestones. Cedillo v. Sec’y of 
Health & Human Servs., No. 98–916V, 2009 WL 331968, at *4 (Fed. Cl. Feb. 12, 2009). 
 86.  Id. at *4–5.  
 87.  Id. at *5. 
 88.  Id. 
 89.  Id. (discussing the testimony of Dr. William Masland). 
 90.  Id. (discussing the testimony of Dr. Karlsson Roth). 
 91.  Id. at *13. The Cedillos first filed in 1998, and then filed an amended petition in 2002. 
 92.  Id. at *15.  
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Cedillos’ counsel, it became a test case for the first general-causation theory.93 
B. A Theory Neither Recognized by the Medical Community nor Supported 
by Science 
Special Master Hastings presided over Michelle’s case.94 He reviewed 
twenty-three medical expert reports and 658 medical journal articles and heard 
testimony from sixteen expert witnesses.95 In February of 2009, he announced 
his decision to deny entitlement. 
Special Master Hastings focused on the Cedillos’ failure to produce 
reputable scientific evidence supporting either a general or a specific theory of 
causation. He found that many of the scientific studies cited “[came] down 
strongly against the petitioners’ contentions” and that “[t]he expert witnesses 
presented by the respondent were far better qualified, far more experienced, 
and far more persuasive than the petitioners’ experts.”96 He noted some of the 
Cedillos’ evidence would not meet the Daubert standard.97 For example, Special 
Master Hastings criticized a general-causation expert whose theory was neither 
recognized by the medical community nor supported by “sound scientific 
methods.”98 Special Master Hastings also found study results supporting the 
Cedillos’ theory of specific causation unreliable.99 He concluded that 
it is extremely unlikely that any of Michelle’s disorders were in any way causally 
connected to her MMR vaccination, or any other vaccination. . . . After studying the 
extensive evidence in this case for many months, I am convinced that the reports and 
advice given to the Cedillos . . . advising the Cedillos that there is a causal connection 
between Michelle’s MMR vaccination and her chronic conditions[] have been very 
wrong. Unfortunately, the Cedillos have been misled by physicians who are guilty, in 
my view, of gross medical misjudgment.
100
 
The same day that Cedillo was announced, Special Masters Vowell and 
Campbell-Smith issued decisions in Snyder and Hazlehurst, respectively, also 
denying entitlement.101 All three test case petitioners applied for review by the 
CFC. Although each of the test case decisions was made individually, they 
involved parallel reasoning. 
In their appeal, the Cedillos alleged that Special Master Hastings had 
required too high a standard of proof,102 citing several Federal Circuit decisions 
 
 93.  Id. at *9.  
 94.  Id. 
 95.  Moreno, supra note 6, at 1514–15. 
 96.  Cedillo, 2009 WL 331968, at *1. 
 97.  Id. at *3, *41, *91 (discussing Daubert and its use in the Vaccine Program, and applying 
Daubert factors to assess the reliability of petitioner’s experts’ unpublished work). 
 98.  Janice G. Inman, The Autism Cases, and What’s Next: Part One of a Two-Part Article, 26 No. 8 
MED. MALPRACTICE L. & STRATEGY 1 (2009) (describing the Cedillo decisions). 
 99.  Id. 
 100.  Cedillo, 2009 WL 331968, at *134–35. 
 101.  Sept. 2010 Autism Update, supra note 2. 
 102.  Brief for Petitioners-Appellants at 15–16, Cedillo v. Sec’y of Health & Human Services, (Fed. 
Cir. 2010) (No. 2010-5004), 2010 WL 464240 (stating the special master “chose to impose upon Michelle 
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that reversed Vaccine Court decisions for applying a standard inconsistent with 
Althen.103 Acknowledging that some of their evidence would not survive a 
Daubert motion, the Cedillos identified several vaccine-injury claims that were 
compensated on the basis of purportedly similar evidence.104 According to the 
Cedillos, what distinguished Michelle’s case from those compensated claims was 
that hers was an autism test case. The Cedillos claimed “the special master 
purposely turned a blind eye on [Michelle’s] evidence . . . [and] inappropriately 
assumed the respondent’s role as protector of the integrity of vaccines.”105 
C. Affirming Rational and Reasonable Decisions 
In 2009, the CFC individually affirmed Cedillo, Hazlehurst, and Snyder.106 
Judge Wheeler issued the Cedillo opinion, agreeing that the Cedillos did not 
meet their prima facie causation burden.107 Judge Wheeler stated that “[the] 
Court [of Federal Claims] will not second guess a Special Master’s fact intensive 
conclusions, especially when medical evidence of causation is in dispute.”108 He 
noted that “[t]he evidentiary record in the [OAP test] cases easily is the largest 
of all cases presented to the Court in the history of the Vaccine Act.”109 He 
found that the special master had exercised valid discretion in choosing to 
discredit certain studies and experts. Judge Wheeler also held that Special 
Master Hastings did not improperly raise the Althen standard.110 Regarding the 
Cedillos’ allegation that a lower standard had been applied in other cases, Judge 
Wheeler noted that “[u]nlike medical issues raised in other Vaccine Act cases, 
autism is not an area ‘bereft of complete proof.’”111 He concluded that Special 
Master Hastings’s decision was “rational and reasonable in all respects” and 
consistent with the law. 112 
Only Cedillo and Hazlehurst were appealed to the Federal Circuit. While 
the appeals were pending, the special masters issued decisions denying 
entitlement in the second theory test cases.113 None of those petitioners 
 
an unattainable standard of proof”). 
 103.  Id. at 19; see also Janice G. Inman, The Autism Cases: In Vaccination Case, Losing Side Casts 
Doubt on Special Master’s Impartiality, Part Two of a Two-Part Article, 26 No. 9 MED. MALPRACTICE 
L. & STRATEGY 1 (2009) (describing the Cedillo decisions).  
 104.  Brief for Petitioners-Appellants, supra note 102, at 20–21. Further, the Cedillos asserted 
Daubert applied solely to judicial review of scientific methods, not to expert conclusions. Id. at 65. 
 105.  Petitioner’s Memo in Support of Motion for Review of Special Master’s Decision of Feb. 12, 
2009 at 4, Cedillo v. Sec’y of Dep’t of Health & Human Servs., No.98-916V (Fed. Cl. Spec. Mstr. Mar. 
16, 2009). 
 106.  Sept. 2010 Autism Update, supra note 2. 
 107.  Cedillo v. Sec’y of Health & Human Servs, 89 Fed. Cl. 158, 183 (2009). 
 108.  Id. at 178 (citing Hodges v. Sec’y of Health & Human Servs., 9 F.3d 958, 961 (Fed. Cir.1993); 
Moberly v. Sec’y Health & Human Servs., 85 Fed. Cl. 571, 597 (2009)).  
 109.  Id. at 167. 
 110.  Id. at 182–83. 
 111.  Id. at 184. 
 112.  Id. 
 113.  Hearings for the second theory were held a year later, in 2008. Sept. 2010 Autism Update, 
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appealed; final judgments were entered in April of 2010.114 
In their appeal to the Federal Circuit, the Cedillos described Michelle’s 
experience in the Vaccine Program as “a disaster.”115 Their appeal concluded 
that 
it is essential that the Vaccine Program, rather than crippling civil litigation, resolve 
[Michelle’s] case as well as those of all autistic children in OAP. Persons fairly 
compensated in the Vaccine Program will not sue manufacturers. How can these 
persons be kept in the Vaccine Program? The answer is simple. An evidentiary 
standard that promotes congressional intent must be employed.
116
 
On May 13, 2010, the Federal Circuit affirmed the rulings below in 
Hazlehurst.117 Then in August of 2010, the Federal Circuit held that it could find 
“no legal error in the standards applied by the special master” in Cedillo. 
Mirroring the Hazlehurst decision,118 the Federal Circuit emphasized the 
importance of the Althen standard, but found the special master’s use of the 
Daubert factors had not undermined Althen.119 The Federal Circuit stated that 
weighing all of the evidence necessitated assessing its reliability120 and cited 
cases that emphasized special masters’ discretion to evaluate the reliability of 
evidence.121 Michelle’s mother commented publically on the decision: “We are 
obviously extremely disappointed. Michelle has a very strong case. The facts in 
her medical records speak for themselves. Our lawyers are currently reviewing 
the decision to see what legal options are available.”122 
Both the Cedillos and the petitioners in Hazlehurst notified the court that 
neither would seek certiorari from the Supreme Court. Subsequently, PSC 
notified the court that no further test cases are contemplated.123 
V 
LESSONS FROM THE AUTISM CASES 
Despite fears to the contrary, given the current state of scientific and 
medical knowledge and standards of proof in the state courts, a flood of civil 
litigation is unlikely to result from the OAP decisions. Evidence that vaccines 
 
supra note 2. 
 114.  Id. 
 115.  Brief for Petitioners-Appellants, supra note 102, at 13. 
 116.  Id. at 57–58.  
 117.  Hazlehurst v. Sec’y of Health & Human Servs, 604 F.3d 1343 (Fed. Cir. 2010). 
 118.  See generally id. 
 119.  Cedillo v. Sec’y of Health & Human Servs., 617 F.3d 1328, 1339 (Fed. Cir. 2010). 
 120.  Id. 
 121.  Id. at 1339 n.3 (citing Moberly v. Sec’y of Health & Human Servs., 592 F.3d 1315, 1325 (Fed. 
Cir. 2010); Terran v. Sec’y of Health & Human Servs., 195 F.3d 1302, 1316 (Fed. Cir. 1999); Perreira v. 
Sec’y of Dep’t of Health & Human Servs., 33 F.3d 1375, 1377 n.6 (Fed. Cir. 1994)). See supra Part 
II.B.2 for a discussion of the standard of proof in off-table claims. 
 122.  Tony Mauro, Federal Circuit Rules No Link Between Autism and Vaccine, NAT’L L.J., Aug. 30, 
2010. 
 123.  Sept. 2010 Autism Update, supra note 2. 
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can cause autism simply is not available to meet the higher standards of proof in 
the civil sphere. There is, however, a more insidious danger underlying the 
autism cases: increasingly negative public opinion toward vaccines generally. 
The government and health professionals have looked to the Vaccine Court to 
emphasize vaccine safety. If the Vaccine Program focuses too much on 
compensation and not enough on science, decisions will implicitly validate 
public fears about vaccines. 
A. The State Court Threat 
Vaccines have been described as “the next big toxic-tort battleground.”124 A 
common refrain of critics is that, by denying entitlement, the Vaccine Court will 
drive autism cases into the civil sphere. At the CFC 2008 Judicial Conference, 
well-known plaintiff’s lawyer Kevin Conway called preventing civil suits the 
Vaccine Act’s “number one” purpose.125 Mr. Conway also stated, “[M]y sense is 
that the [OAP] test cases will certainly result in probably a large majority of the 
cases in the vaccine program leaving . . . and going into the civil arena.”126 The 
Cedillos’ last appeal to the Federal Circuit echoed Conway’s remark.127 
Nevertheless, it is unlikely that the conclusion of the OAP will result in a 
flood of vaccine–autism claims in the civil arena. First, the levels of review 
within the Vaccine Program will likely shield against many autism cases 
reaching state courts.128 Second, evidence linking vaccines and autism is not 
currently available. As one scholar noted, “[b]ecause state courts must deliver 
judgments based on credible evidence that satisfies traditional legal standards, 
claims relying on evidence similar to that presented under the Omnibus Autism 
Proceeding will have difficulty surviving judicial scrutiny.”129 Although 
petitioners will have the benefit of full discovery, “it is highly unlikely that 
[autism] plaintiffs will succeed without additional scientific advancements to 
support their claims.”130 To date, there have been no successful vaccine–autism 
claims in state courts. 
 
 124.  Davis, supra note 5, at 49. 
 125.  Concurrent Vaccine Program/Vaccine Compensation Under the Act: A Mix of Science and 
Policy?, at 16, lines 3–8 (Transcript of 2008 Judicial Conference of the U.S. Court of Fed. Claims) 
[hereinafter 2008 Transcript]. When enacting the Vaccine Act, Congress stated that the “relative 
certainty and generosity of the [Vaccine Program]’s awards [would] divert a significant number of 
potential plaintiffs from litigation.” H.R. REP. No. 99-908, at 13 (1986), reprinted in 1986 U.S.C.C.A.N. 
6344, 6354. 
 126.  Dep’t of Health & Human Servs., Transcript of Advisory Comm’n on Childhood Vaccines 
Meeting 46 (June 10, 2010) [hereinafter Advisory Comm’n June Meeting] (statement of Kevin Conway, 
petitioner’s attorney). 
 127.  See supra, Part III.C (discussing the Cedillos’ appeal to the Federal Circuit). 
 128.  Stewart, supra note 26, at 2499–500. 
 129.  Id. at 2500. 
 130.  Id. Some plaintiffs’ attorneys criticize the limited discovery in Vaccine Court cases as an 
impediment to their success.  
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B. The Resilience of the Autism Controversy in Public Discourse 
The belief that vaccines cause autism raises important issues independent of 
the potential for increased civil litigation. Halfway through the Cedillo hearings, 
the government moved for summary judgment, but stated that it would go 
forward with the proceedings to answer petitioner’s accusations for public 
policy reasons.131 When the special masters released their decisions, HHS 
commented, “Hopefully, the determination by the Special Masters will help 
reassure parents that vaccines do not cause autism.”132 
In the OAP cases, the special masters reviewed a vast amount of scientific 
and medical evidence: twenty-eight medical expert testimonies, fifty expert 
reports, five thousand pages of proceedings, transcripts, and briefs, and nine 
hundred scientific articles.133 The decisions contain careful, analytical 
assessments of the evidence and are readily accessible on the Internet through 
the Vaccine Court’s website.134 They are also complex, lengthy, and detailed. 
Most of the general public will not read the Vaccine Court’s decisions. 
Accordingly, the public’s understanding of the decisions will be informed 
largely by how the media and advocates (on both sides of the vaccine debate) 
portray the decisions. Vaccine-safety proponents are at a disadvantage. It is 
difficult for one hundred and seventy-four pages of scientific data and dry 
expert testimony to effectively counter an emotional story about a child who, 
shortly after being vaccinated, was diagnosed with a serious illness. The Cedillo 
decision thus acknowledges the persuasive power of a temporal narrative.135 
Further, the decisions can point only to a lack of evidence, not a definitive 
answer about vaccine safety.136 
“[P]arents weigh choices about vaccination using conceptions of risk, 
benefit, and trust that are broader than anything that can be demonstrated 
through statistics or biology.”137 The OAP decisions can only affect public 
opinion about vaccines if they “encourage parents to base future healthcare 
 
 131.  Moreland, supra note 55, at 373 (describing the Cedillo hearing). 
 132.  Press Release, Statement from the Department of Health and Human Services Regarding the 
Decisions of the U.S. Court of Federal Claims in the Omnibus Autism Proceedings (Dep’t of Health & 
Human Servs.) (Feb. 12, 2009), available at http://www.hhs.gov/news/press/2009pres/02/20090212a.html. 
 133.  Ross D. Silverman, Litigation, Regulation, and Education—Protecting the Public’s 
HealthThrough Childhood Immunization, 360 NEW ENG. J. MED 2500, 2500 (2009). 
 134.  Moreno, supra note 6, at 1531 (describing the potential impact of the Vaccine Court decisions 
on public opinion because they contain “careful synthesis of available scientific evidence that is easily 
accessible to the public”).  
 135.  Cedillo v. Sec’y of Health & Human Servs., No. 98–916V, 2009 WL 331968, at *135 (Fed. Cl. 
Spec. Mstr. Feb. 12, 2009) (“Nor do I doubt that Michelle’s parents and relatives are sincere in their 
belief that the MMR vaccine played a role in causing Michelle’s devastating disorders. Certainly, the 
mere fact that Michelle’s autistic symptoms first became evident to her family during the months after 
her MMR vaccination might make them wonder about a possible causal connection.”). 
 136.  E.g., Gross, supra note 56, at 6. 
 137.  Silverman, supra note 133, at 2501 (describing the “extremely negative response to the 
decision by the governor of Texas to circumvent the legislature and issue an executive order mandating 
the vaccination of adolescent girls against the human papillomavirus”). 
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decisions on the facts embodied in the growing body of scientific evidence and 
discourage . . . decisions based on fear and faith.”138 The lasting influence of the 
autism controversy has been attributed to a loss of public trust in science.139 
Medical anthropologist Sharon Kaufman, who has studied the vaccine–autism 
controversy, claims “many parents see even the most respected vaccine experts’ 
perspective on the issue as just one more opinion.”140 The structure of the 
Vaccine Program compounds this lack of trust. Fear of government bias 
towards vaccine is a typical complaint of Vaccine Program critics; often 
containing somewhat sensational overtones of government–industry 
conspiracies. One scholar remarked that “NCVIA’s effect on public confidence 
in vaccinations is . . . unclear . . . [but] the act’s relatively broad immunity 
provisions and the barriers it creates for patients seeking jury trials have 
provided rich fodder for people who distrust vaccines.”141 
The autism controversy exemplifies how Vaccine Court decisions can be 
characterized as propaganda for the pharmaceutical industry. In a congressional 
hearing on the vaccine–autism controversy, Congressman Burton stated, “[T]he 
Justice Department filed a motion asking the Special Master to keep all 
information [in a case] secret . . . . That’s very disconcerting to me.”142 He also 
said “The guy who headed that [Vaccine Program] advisory committee had a 
stock in a company that was making the Rotoshield virus vaccine. Shouldn’t 
have done it. He had a tainted point of view.”143 Congressmen Weldon 
described the vaccine-injury problem as “trying to investigate a sacred cow. For 
a lot of people in the medical community, there’s this tremendous fear. If you 
say anything negative about vaccines, then parents will stop vaccinating their 
kids and then you’ll have all these outbreaks of these diseases.”144 Certainly 
many medical and public health professionals have expressed concerns about 
the autism controversy reducing vaccination rates.145 Some critics have 
suggested that the tone of the OAP decisions was so “adamant that . . . the 
judges were aiming to broadcast a statement to the public that vaccines are 
safe.”146 Indeed, the Cedillos suggested that Michelle’s case was treated 
differently because the court had an interest in protecting vaccines. 
 
 138.  Moreno, supra note 6, at 1517. 
 139.  Gross, supra note 56, at 1. 
 140.  Id. at 6. 
 141.  Wendy E. Parmet, Pandemic Vaccines—The Legal Landscape, 362 NEW ENG. J. MED. 1949, 
1950 (2010). 
 142.  Vaccines and the Autism Epidemic: Reviewing the Federal Government’s Track Record and 
Charting a Course for the Future: Hearing Before the H. Comm. on Gov’t Reform, 107th Cong. 7 (2002) 
[hereinafter Autism Hearings] (statement of Rep. Dan Burton). 
 143.  Id. at 27 (statement of Rep. Dan Burton, referring to Dr. Paul Offit). 
 144.  Id. at 6 (statement of Rep. Dave Weldon). 
 145.  See Thomas L. Hafemeister, Other Developments, 27 DEV. MENTAL HEALTH L. 73, 73 (2008) 
(stating that “many doctors and public health officials . . . are concerned that assertions of a vaccine–
autism link may lead parents to forgo vaccinating their children”). 
 146.  Davis, supra note 5, at 53. 
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Critics also suggest that the Vaccine Court is motivated by a desire to 
protect the Vaccine Program itself.147 These critics argue that there is simply not 
enough money in the Vaccine Trust fund to compensate all the autism claims 
pending before the Vaccine Court.148 Following the OAP test case decisions, the 
Department of Justice (DOJ) noted a downward trend in autism cases.149 Critics 
argue that if causation had been established, more claims would have been 
filed. The fact that the Vaccine Program cannot, in its present form, compensate 
the autism claimants is not itself evidence of prejudice. But concern over the 
financial viability of the Vaccine Program inevitably undermines the court’s 
perceived objectivity and impedes its ability to influence public discourse in 
favor of vaccines. This is not to suggest that the Vaccine Court does not have 
the capacity to influence public opinion. The standard of proof in vaccine-injury 
cases makes a critical statement to the public about vaccine safety. 
C. Clarifying Althen: The Need for a More Scientific Standard of Proof 
Vaccine–autism claimants and supporters have alleged that they face a 
higher burden of proof than other vaccine-injury claims, frustrating 
congressional intent.150 Throughout Cedillo, the petitioner questioned the 
standard of proof applied in the case. Complaints about the standard of proof 
are not unique to autism claims. The Vaccine Program has long been criticized 
as being as adversarial as the tort system, and the DOJ has been criticized for 
being overzealous in its defensive role.151 In off-table claims in particular, critics 
argue that the petitioner does the “heavy lifting” and that the government tends 
to assume “a more adversarial position.”152 This criticism is not entirely 
unfounded. In a 2001 congressional hearing, the director of the NVICP stated, 
“The program significantly reduces, but cannot eliminate, the tension and 
 
 147.  Id. at 51 (“Parents and their lawyers . . . [have] been vocal critics of the vaccine court, arguing 
that the judges decided to ‘protect’ the vaccine program by reassuring parents that vaccinations are 
safe, rather than fulfilling their responsibility to help injured children.”). 
 148.  See Shemin, supra note 7, at 493 n.185 (“Simple calculation demonstrates that there is 
currently not enough money in the Vaccine Trust Fund to compensate the approximately 4900 claims 
should the special masters find in their favor.”); Moreland, supra note 55, at 369 (stating that the 
NVICP “could be bankrupt if petitioners in autism cases are given compensation through the 
Program”). 
 149.  Advisory Comm’n June Meeting, supra note 126, at 10 (statement of Geoffrey Evens, Dir., 
Div. of Vaccine Injury Comp. Program). 
 150.  Davis, supra note 5, at 51. Alexandra Dunn, Assistant Dean of Environmental Law Programs 
at Pace Law School, commented, “The disappointing factor here is that a court that was created to be 
the best venue for these injuries is not fulfilling its purpose . . . . Over time, when it comes to [autism 
claims], the court seems to be raising the bar for causation.” Id. 
 151.  The National Vaccine Injury Program: Is It Working As Congress Intended?: Hearing Before 
the H. Comm. on Gov’t Reform, 107th Cong. 3 (2001) [hereinafter NVIP Hearing] (statement of Rep. 
Dan Burton) (“The Government hires teams of medical witnesses to try to disprove families’ cases. . . . 
We’re supposed to be helping these people. But if you talk to some of these families, they feel like 
they’ve been put through the wringer by their own Government.”). 
 152.  Shemin, supra note 7, at 476. 
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adversity inherent with any litigation process for resolving claims.”153 Paul 
Harris, representing the DOJ, attributed petitioners’ complaints not to 
adversity within the system, but to “denial of scientifically unsupported 
petitions.”154 
In 2010, the DOJ reported a forty percent compensation rate for vaccine-
injury claims including the autism cases, but a sixty-six percent compensation 
rate for injury claims excluding autism cases.155 DOJ Deputy Director Mark 
Rogers stated, “We’ve been tracking the autism cases separately because we 
think they mask the background performance of the program.”156 This 
statement implicitly suggests that the rate of compensation measures the success 
of the Vaccine Program and demonstrates a fundamental flaw in how people 
think about the system. As the Director of the NVICP remarked in 2001, “the 
program was never intended to serve as a compensation source for wide range 
of naturally occurring illnesses and conditions, which unfortunately affect many 
of our children.”157 Instead, the program was intended to compensate for 
vaccine-related injuries. Its success, therefore, should not be defined by its rate 
of compensation independent of whether the claims merit compensation. 
Admittedly, vaccine injuries are difficult to prove. In creating the Vaccine Act, 
Congress stated, “The Committee recognizes that there is public debate over 
the incidence of illnesses that coincidentally occur within a short time of 
vaccination. The Committee further recognizes that the deeming of vaccine-
relatedness adopted here may provide compensation to some children whose 
illness is not, in fact, vaccine-related.”158 Recognizing that some undeserving 
claims will be compensated is not an endorsement of compensating frivolous 
claims. 
Compensating for vaccine injuries is only one of the Vaccine Program’s 
multiple goals. The Vaccine Program is also intended to promote vaccine 
production and protect immunization programs and practices. These goals, 
although not fundamentally inconsistent, are best served by different standards 
of proof. A lower standard that liberally compensates petitioners may satisfy 
them and divert them from state courts. But it also may decrease public 
confidence in the safety of vaccines that actually cause injury to only a very 
small number of persons. 
 
 153.  NVIP Hearing, supra note 151, at 59 (statement of Thomas E. Balbier, Jr., Dir., Nat’l Vaccine 
Injury Comp. Program). 
 154.  Id. at 85 (written statement of Paul C. Harris, Sr., Deputy Assistant Att’y Gen., Civil Div., U.S. 
Dep’t of Justice). 
 155.  Advisory Comm’n June Meeting, supra note 126, at 24–25 (statement of Mark Rogers, Deputy 
Dir., U.S. Dep’t of Justice). 
 156.  Id. at 24. 
 157.  NVIP Hearing, supra note 151, at 60 (statement of Thomas E. Balbier, Jr., Dir., Nat’l Vaccine 
Injury Comp. Program). 
 158.  H.R. REP. No. 99-908, at 18 (1986), reprinted in 1986 U.S.C.C.A.N. 6344, 6359. The Cedillos 
quoted this passage in their appeal to the Federal Circuit. 
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With Althen and Andreu, the Federal Circuit expressly rejected a heavily 
scientific standard.159 After Althen, special masters cannot require medical 
literature to support a claim or the identification of a specific biologic 
mechanism.160 But Althen did not dismiss the need for theories of causation to 
be supported by “reputable medical or scientific explanation[s],”161 leaving the 
standard of proof unclear. Both Special Master Hastings’ and Judge Wheeler’s 
remarks in their respective Cedillo decisions indicate that the Cedillos lacked 
credible evidence to satisfy any standard of causation. Nevertheless, both judges 
suggested that there may be different, result-changing standards of causation 
for off-table claims. During the 2008 Judicial Conference, vaccine expert Dr. 
Paul Offit argued it would be possible to prove that peanut butter sandwiches 
cause cancer under the Althen standard.162 Because the majority of claims are 
now off-table and one of the goals of the Vaccine Court is the consistent and 
streamlined adjudication of cases, a well-defined standard of proof is critical to 
the functionality of the program.163 
The standard of proof is not merely a legal issue. The autism cases also 
exemplify how the standard of proof may impact public health. Dr. Offit 
warned that the Vaccine Court “has a tremendous responsibility and needs to 
realize that [it does] send a message with certain decisions [it] make[s].”164 He 
stated that moving away from a scientific standard “in the name of policy . . . 
run[s] the risk of sending the message . . . that vaccines are causing harms that 
they don’t.”165 Outbreaks of vaccine-preventable disease often start with persons 
who refuse vaccination; children exempted from immunization requirements 
are more likely to contract or transmit vaccine-preventable diseases.166 An 
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unscientific standard of proof may not only allow compensation of claims in 
which vaccines did not cause injuries, but may also affect public perceptions 
about vaccine safety. The worst case scenario is not, as petitioner’s attorney 
Kevin Conway suggested, merely compensating an ineligible claim.167 “[A] court 
ruling linking autism to vaccines could spur parents to eschew immunizations, 
sparking a potentially deadly epidemic . . . [and] a resurgence of potentially 
fatal diseases.”168 
The serious consequences of low public confidence in vaccine safety are not 
purely speculative. The vaccine–autism controversy has led some parents to 
delay or refuse to vaccinate their children. Recently, the number of nonmedical 
exemptions sought from immunization requirements has risen.169 In 2008, the 
largest outbreak of measles in the United States since 2000 was reported. This 
outbreak was tied to exemptions from routine immunizations.170 
Further, a scientific standard is not inconsistent with congressional intent. 
At the Vaccine Program’s conception, Congress stated, “No-fault vaccine 
compensation proceedings raise fewer legal issues than issues of medicine.”171 In 
the interest of compensating generously, the Vaccine Court should be flexible 
and open to new science. Liberality is built into the structure of the Vaccine 
Program. Because the Vaccine Court is not governed by federal evidentiary 
rules, “petitioners may introduce a broader array of documentation . . . 
including expert medical opinion, circumstantial evidence, and widely accepted, 
albeit unproven, scientific theories.”172 The legislative history of the Vaccine Act 
does not indicate Congress approved of an even lower standard. Indeed, 
Congress rejected legislation in 2001 to lower the standard of proof173 after 
public health officials expressed concerns that moving away from “a scientific 
evaluation of the connection between the injury and the vaccine” might open 
up compensation too broadly.174 
Current direction from the Federal Circuit, however, may be inconsistent 
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with congressional intent. Concluding his decision to deny entitlement, Special 
Master Hastings asserted: “I have not required a level of proof greater than 
‘more probable than not.’ . . . [T]his is a case in which the evidence is so one-
sided that any nuances in the interpretation of the causation case law would 
make no difference to the outcome of the case.”175 
Special Master Hastings was referring to Althen, which instructed special 
masters to resolve “close calls regarding causation . . . in favor of injured 
claimants.”176 If by “close call” the Federal Circuit meant that cases in which the 
petitioner’s favorable evidence is only slightly greater than that of respondent’s, 
the instruction seems unnecessary. In such cases, the petitioner has met his 
burden. But if the Federal Circuit meant cases in which the evidence is in 
equipoise should be resolved in favor of the petitioner, this direction seems 
inconsistent with the text of the Vaccine Act.177 In Cedillo, Special Master 
Hastings notes, “Congress designed the Program to compensate only the 
families of those individuals whose injuries or deaths can be linked causally, 
either by a Table Injury presumption or by a preponderance of causation-in-fact 
evidence, to a listed vaccination.”178 The Vaccine Act explicitly requires proving 
causation-in-fact in off-table claims by a preponderance of the evidence.179 
Finally, an explicitly non-scientific standard of proof makes adjudication of 
vaccine-injury cases all the more challenging for the court and the parties.180 The 
autism cases are an extreme example of how vaccine claims are increasingly a 
battle of experts. Although the Cedillo decisions held that the evidence 
supporting a link between vaccines and autism was not compelling, proponents 
of the vaccine–autism theory adamantly disagree. In their appeal to the Federal 
Circuit, the Cedillos characterized the respondent’s experts as “honest scientists 
who strongly disagree with the conclusions of the petitioners’ experts.”181 The 
Vaccine Court must have appropriate metrics for assessing experts’ claims. 
Uncertainty does not obviate the need for the scientific method, it demonstrates 
it. Science should be determined through the scientific method, not through the 
courts.182 As Judge Wheeler stated, “[t]he issue before [the] Court is not to 
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determine the causes of autism. The Court can only hope that medical 
professionals succeed in identifying the causes and developing a cure for this 
tragic disease.”183 
VI 
CONCLUSION 
The Vaccine Court sits at the intersection of law and public health. 
Although many have expressed concerns that the decision to deny entitlement 
in the autism cases will result in a flood of civil litigation, this is unlikely given 
the evidence available. Although the Vaccine Program may stave off state court 
suits, public health officials cannot rely on Vaccine Court decisions to restore 
lost trust in science and resolve the vaccine–autism controversy. The current 
standard of proof in the Vaccine Program threatens to undermine public 
confidence in the safety of vaccines. To protect the integrity of U.S. vaccination 
policy, the Federal Circuit should announce a clearer, more rigorously scientific 
standard of proof for causation in off-table vaccine-injury claims. 
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